TABLE 3.

Secondary Outcomes; Hematological Indices Across Study Period

	Intervention n = 40	Usual Care n = 32	P
Hemoglobin values, g/dL*
Randomization	10.7 ± 1.3, n = 40	10.6 ± 1.4, n = 32	0.76
Admission	11.5 ± 1.3, n = 36	10.7 ± 1.7, n = 29	0.12
Difference between randomization and admission	0.8 ± 0.8, n = 36	0.1 ± 1.3, n = 29	0.01
Discharge	10.3 ± 1.3, n = 37	10.2 ± 0.9, n = 31	0.31
4 wk	12.2 ± 1.2, n = 36	11.1 ± 1.2, n = 28	<0.001
Postdischarge change (4 wk minus discharge value)	1.9 ± 1.4, n = 36	0.9 ± 1.4, n = 28	0.01
Iron status†
Ferritin at randomization, μg/L	19 (6–48), n = 40	37 (11–82), n = 32	0.06
Ferritin at 4 wk, μg/L	248 (137–546), n = 36	99 (35–228), n = 27	0.002
Transferrin saturation at randomization, %	6 (3–10), n = 40	9 (7–15), n = 32	0.03
Transferrin saturation at 4 wk, %	21 (16–26), n = 36	14 (7–18), n = 27	0.003
CRP†
CRP at randomization, mg/L	7.2 (2.9–19.3), n = 40	7.7 (2.6–16.8), n = 32	0.99
CRP at 4 wk, mg/L	5.8 (2.3–12.6), n = 36	11 (3.1–23), n = 27	0.18

Sample size varies due to missing values at each time point.

^*Data presented as mean ± SD.

^†Data are expressed as median (IQR).